🔎 Trials Near Me

Home › Lymphoma › Iowa › Cedar Rapids

Lymphoma clinical trials in Cedar Rapids, IA

6 studies for Lymphoma are looking for participants at sites in and around Cedar Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

RecruitingPhase 2
  • University of Iowa, Iowa City · 25 mi away
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07221500

Collection of Tissue Samples for Cancer Research

RecruitingObservational study
  • University of Iowa, Iowa City · 25 mi away
2 Months · All sexes · Updated Sep 16, 2026 · NCT00900198

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

RecruitingPhase 3
  • University of Iowa, Iowa City · 25 mi away
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06084936

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

RecruitingPhase 1/2
  • University of Iowa, Iowa City · 25 mi away
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

RecruitingPhase 1
  • University of Iowa Health, Iowa City · 25 mi away
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07192471

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

RecruitingPhase 3
  • University of Iowa, Iowa City · 25 mi away
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07188558

About Lymphoma

Lymphoma is a cancer affecting the immune system. Hodgkins Lymphoma and Non Hodgkins Lymphoma are types of lymphoma. Learn about symptoms and treatments.

More about Lymphoma on MedlinePlus

Lymphoma trials in other cities

Other studies in Cedar Rapids

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.